Health News

The National Science Foundation (NSF) has awarded The University of Texas at Arlington a $1.1 million grant to train and mentor three multi-level cohorts of interdisciplinary researchers in mathematical and computational techniques to address questions in cancer biology, computational neurology and vector-borne diseases.

Indiana University School of Medicine researchers have uncovered vital insights regarding a liver trigger that blocks an undesired immune response from gene therapy, surprisingly resulting in the activation of specific immune cells, despite the liver’s typical role in suppressing immune responses.

Study explores optimizing large language models (LLMs) for differential diagnosis (DDx), demonstrating their potential in assisting clinicians with accurate disease diagnosis using real-world medical cases.

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

Study reveals societal stigma and negative stereotypes associated with acne, highlighting the need for greater awareness and understanding of this skin condition.

A systematic review and meta-analysis in Scientific Reports finds no significant difference between paracetamol and ibuprofen in treating episodic tension-type headaches, suggesting both as viable options for pain relief.

The Biden administration’s assertion of its authority to exercise “march-in” rights is causing uncertainty over the extent to which drugmakers may lose monopolies and consumers will save money.

This week on “The Readout LOUD” podcast: How does the first CRISPR treatment work? Can biotech rebound? And when is $300 million not $300 million?

Maternal inflammation risk factors may be associated with dysregulation in children, according to a study funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health.

The lab of Yongchao C. Ma, PhD, at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago uncovered a novel mechanism that leads to motor neuron degeneration in spinal muscular atrophy (SMA).

A fast-dissolving vaginal insert that women would use at or around the time of sex as an “on-demand” HIV prevention method is being evaluated in a new early phase study being conducted by MATRIX, a United States Agency for International Development (USAID)-funded project focused on the early research and development of innovative HIV prevention products for women.

Researchers led by François Fuks – Laboratory of Cancer Epigenetics, ULB Faculty of Medicine, ULB Cancer Research Center and Jules Bordet Institute, H.U.B. – have made a major breakthrough in the understanding and treatment of leukemia.

Researchers have successfully demonstrated a proof of concept for using a 3D printer to print biomaterials directly inside an organ.

Medtronic is no longer buying EOFlow, a Korean maker of wearable insulin pumps. The news comes three months after Insulet, EOFlow’s rival, filed a lawsuit accusing the company of stealing…

Two lawmakers launched a bipartisan investigation into private equity ownership of hospitals, citing concerns that such arrangements are bad for both healthcare providers and patients.

White House officials will take more time to review the FDA’s plan to ban menthol cigarettes, a delay that anti-tobacco groups fear could scuttle the rule.

Senate health committee chair Bernie Sanders (I-Vt.) is planning to return to the issue of diabetes with another hearing next week.

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. Before we get to the serious news of the…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with another multibillion-dollar deal,…

The White House is throwing its support behind a controversial authority that allows the government to claw back patents for certain high-priced drugs.